Medical Cannabis - A General Population Survey | cannabisMD

Medical Use of Cannabis – A Survey of the General Population

A survey on The General Public and Medical Cannabis Use

Medical Marijuana in Treating Pain and HIV

Medical cannabis has increased in popularity by the general public and in the medical and beauty industry due to it’s beneficial and medical effects and in treating a wide range of ailments. Two of these ailments that this particular study concentrates on are, pain and HIV/AIDS.

Medical cannabis has been used as a medicine as far back as 10’000 BC in ancient China, and it’s only now that we are starting to see its benefits. To this day, people around the work are using medical cannabis to treat pain (however, this can only be done in countries where medical marijuana is legal).

Here is the full scientific article if you wish to download it.

The Study on Medical Cannabis and Neuropathic Pain and HIV

Benefits of cannabis as a medicinal agent for a variety of conditions, including neuropathic pain due to HIV distal sensory polyneuropathy were examined in this study. Existing analgesic and adjunctive treatments are inadequate; neuropathic pain in DSPN persists in many cases despite attempts at management with:

  • Opioids
  • Nonsteroidal anti-inflammatory agents
  • Adjunctive pain modifying therapies

But because of these, patients suffer unfavourable side effects which in turn can majorly their quality of life. In this randomized clinical trial, smoked cannabis at a maximum tolerable dose, significantly reduced neuropathic pain intensity in HIV-associated DSPN compared to placebo, when added to stable concomitant analgesics.

The Results of the Study and What It Suggests

Cannabis was associated with a sizeable and significantly greater proportion of patients who achieved what is generally considered clinically meaningful pain relief. Thus, one recent inpatient randomized clinical trial of painful DSPN noted that inhaled cannabis, in doses comparable to those in the present report, significantly reduced pain intensity compared to placebo.

Two other placebo-controlled studies of neuropathic pain associated with multiple sclerosis indicated that both sublingual D-9-THC alone or with cannabidiol, and oral synthetic D-9-THC significantly outperformed placebo.

Jonathan Neilly
Jonathan Neilly
Jonathan Neilly is registered with the British Psychological Society, breaking the taboo on mental health issues is one of the driving forces in his life. His background in biomedicine gives him additional understanding of the factors that work together to influence the human condition.

Leave a Reply

Your email address will not be published. Required fields are marked *